Association of breast cancer grade with response to neoadjuvant chemotherapy assessed postoperatively
Polish Journal of Pathology · 29.08.2019 · 70 (2) · 91-99
DOI: 10.5114/pjp.2019.87101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polish Journal of Pathology, online erschienen am 29.08.2019. Verfasst von Michał Jarząb und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Jinan Central Hospital Affiliated to Shandong University, Shandong University, Jinan, Shandong Province, People's Rep…. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Neoplasm Grading. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Currently, breast cancer chemotherapy response can be predicted based on various parameters, with common reporting of tumour grade and Ki67 proliferation index. We analysed their association with pathological complete response (pCR) in a multivariate approach.
The study was carried out in a group of 353 patients, treated by preoperative chemotherapy and prospectively observed. In selected patients, parallel to routing core needle biopsy assessment, gene expression profile of tumour was analysed by oligonucleotide microarrays.
Tumour parameters associated with pCR in univariate analysis were: tumour grade, nuclear grade, mitotic index, Ki67, oestrogen and progesterone receptor (all p < 0.0001), and triple-negative status (p = 0.0032). The highest increase of pCR chance was observed in patients with high-grade tumours and with Ki67 ≥ 20%. In multivariate analysis, only tumour grade and oestrogen receptor status were predictive for pCR independently of other variables, with high grade increasing the odds of pCR 2.42 fold, and high ER decreasing the chance of pCR 0.41 fold. Tumour grading reflects important biological features of breast cancer and is not inferior to proliferation markers, including Ki67. It should be taken into account in decision-making for preoperative chemotherapy in parallel to breast cancer biologic subtypes, because grade 3 tumours exhibit a higher proportion of pCR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Jinan Central Hospital Affiliated to Shandong University, Shandong University, Jinan, Shandong Province, People's Republic of China.
Zitieren
APA
Jarząb, M., Stobiecka, E., Badora-Rybicka, A., Chmielik, E., Kowalska, M., Bal, W., Polakiewicz-Gilowska, A., Bobek-Billewicz, B., Lange, D., & Tarnawski, R. (2019). Association of breast cancer grade with response to neoadjuvant chemotherapy assessed postoperatively. Polish Journal of Pathology, 70(2), 91-99. https://doi.org/10.5114/pjp.2019.87101
Vancouver
Jarząb M, Stobiecka E, Badora-Rybicka A, Chmielik E, Kowalska M, Bal W, et al. Association of breast cancer grade with response to neoadjuvant chemotherapy assessed postoperatively. Polish Journal of Pathology. 2019;70(2):91-99. doi:10.5114/pjp.2019.87101
BibTeX
@article{Jarzb2019,
author = {Jarząb, Michał and Stobiecka, Ewa and Badora-Rybicka, Agnieszka and Chmielik, Ewa and Kowalska, Małgorzata and Bal, Wiesław and Polakiewicz-Gilowska, Anna and Bobek-Billewicz, Barbara and Lange, Dariusz and Tarnawski, Rafał},
title = {Association of breast cancer grade with response to neoadjuvant chemotherapy assessed postoperatively},
journal = {Polish Journal of Pathology},
year = {2019},
volume = {70},
number = {2},
pages = {91--99},
doi = {10.5114/pjp.2019.87101}
}
EUVIMED